Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin effect on Rosuvastatin PK in White and Asian volunteers
NCT02106767Phase 1Completed
- Sponsor
- University of California, San Francisco
- Start
- Nov 2014
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of rosuvastatin in hypercholesterolemia, sponsored by University of California, San Francisco. Started Nov 2014; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02106767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02106767.